Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19

@article{Lauriola2020EffectOC,
  title={Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19},
  author={Marinella Lauriola and Arianna Pani and G. Ippoliti and A. Mortara and S. Milighetti and Marjieh Mazen and Gianluca Perseghin and D. Pastori and Paolo Grosso and F. Scaglione},
  journal={Clinical and Translational Science},
  year={2020},
  volume={13},
  pages={1071 - 1076}
}
  • Marinella Lauriola, Arianna Pani, +7 authors F. Scaglione
  • Published 2020
  • Medicine
  • Clinical and Translational Science
  • Conflicting evidence regarding the use of hydroxychloroquine (HCQ) and azithromycin for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection do exist. We performed a retrospective single‐center cohort study including 377 consecutive patients admitted for pneumonia related to coronavirus disease 2019 (COVID‐19). Of these, 297 were in combination treatment, 17 were on HCQ alone, and 63 did not receive either of these 2 drugs because of contraindications. The… CONTINUE READING
    4 Citations

    References

    SHOWING 1-10 OF 31 REFERENCES
    Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
    • 732
    • PDF
    Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
    • 2,426
    • PDF
    A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
    • 2,359
    • PDF
    Impact of disease on plasma and lung exposure of chloroquine, hydroxy‐chloroquine and azithromycin: application of PBPK modelling
    • 9